Cushing Syndrome

Search Trials
A Study to Evaluate the Efficacy and Safety of Maralixibat in Subjects With Progressive Familial Intrahepatic Cholestasis (MARCH-PFIC)
Status:
Recruiting
Last Changed:
Aug 7, 2019
First Changed:
Apr 5, 2019
Disease(s):
Progressive Familial Intrahepatic Cholestasis (PFIC)
Intervention(s):
MaralixibatPlacebo
A Placebo-controlled Study of Maralixibat (SHP625) in Pediatric Subjects With Progressive Familial Intrahepatic Cholestasis (PFIC)
Status:
Withdrawn
Last Changed:
Mar 18, 2019
First Changed:
Nov 27, 2017
Disease(s):
Progressive Familial Intrahepatic Cholestasis (PFIC)
Intervention(s):
MaralixibatPlacebo
Heart Disease Risk Factors in Major Depression
Status:
Completed
Last Changed:
Jul 2, 2017
First Changed:
Jan 19, 2000
Disease(s):
Adrenal Gland Hyperfunction
Efficacy and Safety of Pasireotide Administered Monthly in Patients With Cushing’s Disease
Status:
Completed
Last Changed:
May 22, 2018
First Changed:
Jun 16, 2011
Disease(s):
Cushing's Disease
Intervention(s):
pasireotide LARSOM230 LAR 30 mgSOM230 LAR 10 mg
Study of Adrenal Gland Tumors
Status:
Recruiting
Last Changed:
Dec 24, 2018
First Changed:
Jun 29, 2000
Disease(s):
Adrenal Gland Neoplasm

Connect. Empower. Inspire.